NEW HAVEN, Conn., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Dr. Milind Deshpande, President of Research and Development and Chief Scientific Officer, will provide a corporate update at the upcoming Credit Suisse 2011 Healthcare Conference on Wednesday, November 9, 2011 at 3:30 p.m. MT (5:30 p.m. ET) at the Arizona Biltmore Hotel, Phoenix, AZ.
